Chondramine, tablets 10 mg, 40 pcs.

Diseases of the musculoskeletal system caused by pathologies of connective tissue and cartilaginous structures are widespread in the population.

The urgency of solving the problem of effective care for patients with this pathology is very high, since it often leads to significant limitation of work capacity as well as to disability. Etiopathogenetic factors which contribute to the development of connective tissue diseases are manifold, that is why Chondramin has been developed for the correction and prevention of connective tissue disorders which occur in various diseases.

• It has a selective effect on cartilage cells and improves metabolism in chondrocytes, which protects the joints from various lesions and normalizes their function.
• Activates cartilage and connective tissue repair in arthritis, arthrosis, osteochondrosis, rheumatic diseases and injuries of the musculoskeletal system, reduces pain and stiffness of joints.
• It is recommended for increased physical activity and sports activities, as well as for the elderly.

The components of Chondramine derived from cattle cartilage are a complex of proteins and nucleoproteins with a selective action on cartilage cells, which helps normalize metabolic processes in chondrocytes and reduces the possibility of various joint lesions.

The clinical trials of Chondramine were conducted in 120 patients with osteoarthritis of the knee joints, osteochondrosis of the spine and systemic osteoporosis.

The effectiveness of Chondramin use was evaluated based on the dynamics of subjective complaints and objective indices of laboratory and instrumental examinations, as well as on the monitoring of the functional state of the musculoskeletal system.

In the course of clinical tests it was found that a course of administration of “Hondramine” in the complex therapy contributed to the decrease of pain syndrome and stiffness of the joints of patients. The most characteristic effect of Hondramine was the reduction of pain syndrome and an increase in the volume of motion in the affected joints.

On the background of taking Hondramin all patients had a significant smoothing of the pathological symptomatology, usually characterized by significant resistance to therapy. The degree of clinical effect depended on the stage of the disease: dynamics were less pronounced in older and elderly patients, but these subjective sensations were evaluated as very favorable for the older patients.

“Hondramine” is recommended to accelerate the processes of cartilage regeneration in inflammatory and metabolic-dystrophic joint lesions of the limbs and spine, malnutrition, exposure of the body to various extreme factors, as well as in case of heavy physical exertion and in sports of the highest achievements.

“Hondramine” is recommended to the elderly and elderly people to maintain normal functioning of the musculoskeletal system.

Indications

Composition

1 tablet contains:

the active ingredient:

Protein and nucleoprotein complex isolated from bovine cartilage 10 mg

How to take, the dosage

Take 1-3 tablets 2-3 times a day 10-15 minutes before a meal with water, without chewing.

The course: 30-45 days.

The course is repeated in 3-6 months.

Contraindications

Individual intolerance to the components of the product, pregnancy, breast-feeding.